Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
2000 Turkeys
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
2000 Turkeys
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Provention Bio, Inc. - Common Stock
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
DexCom, Inc. - Common Stock
(NQ:
DXCM
)
79.41
-5.05 (-5.98%)
Delayed Quote
Updated: 4:00 PM EST, Nov 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about DexCom, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
37
38
Next >
S&P 500 Top Movers: Nov. 6, 2026 Gainers and Losers
↗
November 06, 2026
Via
Chartmill
Topics
Stocks
S&P 500 Top Movers: Gainers and Losers on Nov. 6, 2026
↗
November 06, 2026
Via
Chartmill
Topics
Stocks
2 cash-producing stocks to research further and 1 facing challenges
November 05, 2026
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not...
Via
StockStory
2 profitable stocks on our buy list and 1 we avoid
November 04, 2026
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
Via
StockStory
DexCom (NASDAQ:DXCM): Affordable Growth at a Reasonable Valuation
↗
October 13, 2026
Via
Chartmill
DexCom (NASDAQ:DXCM): Strong Growth Paired With a High-Quality Technical Setup
↗
October 02, 2026
Via
Chartmill
DexCom (NASDAQ:DXCM): An Affordable Growth Play With Strong Momentum and Fair Valuation
↗
August 27, 2026
Via
Chartmill
AdaptHealth, Align Technology, Acadia Healthcare, DexCom, and STERIS shares are soaring, what you need to know
November 04, 2026
What happened? A number of stocks jumped in the afternoon session after election results confirmed that Democrats reclaimed majorities in the House and Senat...
Via
StockStory
3 quality compounders with promising prospects
November 01, 2026
A quality compounder is a business that not only sports durable competitive advantages but also builds on its success by consistently reinvesting its profits...
Via
StockStory
S&P 500 Unusual Volume Movers for Oct. 30, 2026
↗
October 30, 2026
Via
Chartmill
Topics
Stocks
DXCM Q3 deep dive: clinical momentum and new product launches support growth trajectory
October 30, 2026
Medical device company DexCom (NASDAQ:DXCM) reported revenue ahead of Wall Street’s expectations in Q3 2026, with sales up 11.2% year on year to $1.34 billio...
Via
StockStory
Dexcom (DXCM) Q3 2026 Earnings Call Transcript
↗
October 30, 2026
Record patient starts and type 2 diabetes share gains fuel 11% revenue growth.
Via
The Motley Fool
Topics
Earnings
What DexCom (DXCM) Said on Its Q3 Earnings Call
↗
October 29, 2026
DexCom (NASDAQ:DXCM) reported third-quarter 2026 revenue of $1.34 billion, up 11% from a year earlier on both a reported and organic basis, as U.S. growth, market-share gains and manufacturing...
Via
MarketBeat
Topics
Earnings
Initial Public Offering
2 Stocks That Could Quietly Become Big Winners in the Artificial Intelligence (AI) Revolution
↗
October 29, 2026
These aren’t top AI stocks, but the technology is helping improve their businesses.
Via
The Motley Fool
Topics
Artificial Intelligence
DexCom (NASDAQ:DXCM) beats Q3 2026 sales expectations
October 29, 2026
Medical device company DexCom (NASDAQ:DXCM) reported Q3 2026 results beating Wall Street’s revenue expectations, with revenue up 11.2% year on year to $1.34 ...
Via
StockStory
What to expect from DexCom’s (DXCM) Q3 earnings
October 27, 2026
Medical device company DexCom (NASDAQ:DXCM) will be reporting results this Thursday after the bell. Here’s what investors should know. DexCom beat analysts’ ...
Via
StockStory
S&P 500 Unusual Volume Movers in Today's Session
↗
October 22, 2026
Via
Chartmill
Topics
Stocks
S&P 500 Top Movers: Oct. 21, 2026 US Session
↗
October 21, 2026
Via
Chartmill
Topics
Stocks
S&P 500 Top Movers on Oct. 21, 2026: Supermicro Leads Gainers, Dexcom Leads Losers
↗
October 21, 2026
Via
Chartmill
Topics
Stocks
These S&P500 stocks that are showing activity before the opening bell on Thursday.
↗
October 15, 2026
Via
Chartmill
Uncover the latest developments among S&P500 stocks in today's session.
↗
October 06, 2026
Via
Chartmill
Which S&P500 stocks are moving on Tuesday?
↗
October 06, 2026
Via
Chartmill
Tuesday's session: gap up and gap down stock in the S&P500 index
↗
October 06, 2026
Via
Chartmill
2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds
September 25, 2026
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are...
Via
StockStory
Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring
↗
September 22, 2026
Oura's IPO targets a $12.8B-$14.1B valuation, pricing shares at $40-$44 ahead of its Nasdaq debut, backed by Eli Lilly interest and strong subscription revenue growth.
Via
MarketBeat
Topics
Initial Public Offering
2 Nasdaq 100 Stocks for Long-Term Investors and 1 We Turn Down
September 21, 2026
The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing. However, certain stocks in the index face challenges like ...
Via
StockStory
2 Unpopular Stocks That Should Get More Attention and 1 We Question
September 18, 2026
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...
Via
StockStory
3 Quality Compounders with Impressive Fundamentals
September 10, 2026
A quality compounder is a business that not only sports durable competitive advantages but also builds on its success by consistently reinvesting its profits...
Via
StockStory
Q2 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks
September 02, 2026
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the patient monitoring stocks, including DexCom (NASDAQ:DXCM) and its peers. Patient mo...
Via
StockStory
Topics
Artificial Intelligence
3 Reasons DXCM Has Explosive Upside Potential
September 01, 2026
Over the past six months, DexCom has been a great trade, beating the S&P 500 by 11.5%. Its stock price has climbed to $91.17, representing a healthy 23.6% in...
Via
StockStory
Topics
Stocks
< Previous
1
2
3
4
5
6
7
8
9
...
37
38
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today